Clinical Trial Update: Burden of Illness in Atrial Fibrillation

View source ↗

Summary

A Bayer-sponsored clinical trial evaluating the burden of illness in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED